Quantcast

Latest Baxter International Stories

2009-01-05 07:00:00

DEERFIELD, Ill. and SAN DIEGO, Jan. 5 /PRNewswire-FirstCall/ -- Baxter International Inc. and Halozyme Therapeutics, Inc. (Nasdaq: HALO) today announced the start of a Phase III clinical trial of Baxter's GAMMAGARD LIQUID [Immune Globulin Intravenous] 10% (IGIV), marketed as KIOVIG in the European Union, with Halozyme's recombinant human hyaluronidase enzyme (rHuPH20, Enhanze(TM) Technology) for the treatment of primary immunodeficiency (PID). The purpose of this clinical trial is to...

2008-12-22 11:36:24

The cause of an outbreak of severe adverse reactions that occurred at hemodialysis facilities across the country early this year has been identified. Vials of heparin manufactured by Baxter Healthcare and contaminated with oversulfated chondroitin sulfate (OSCS) have been shown to be responsible for a widespread outbreak of adverse reactions to hemodialysis treatment that affected 152 people and covered 13 states. Reactions to the contaminated heparin included facial edema, or swelling, low...

2008-11-04 18:00:19

Baxter International Inc. (NYSE: BAX) announced today that it will present at the 2008 Annual Credit Suisse Health Care Conference on Wednesday, November 12, 2008 at 8:30 a.m. (MST) or 10:30 a.m. (EST). The live webcast of Baxter's presentation can be accessed from the Baxter corporate website at http://investor.baxter.com/phoenix.zhtml?c=86121&p=irol-EventDetails&E ventId=2012057 and will be available for replay through December 11, 2008. Baxter International Inc. develops,...

2008-10-08 09:00:51

While peritoneal dialysis home therapy (PD) was originally introduced 30 years ago to offer patients with kidney failure a better way to filter toxins and fluids from the body overnight or several times a day in the convenience of their home, the economic advantages of PD have taken on increasing importance and visibility due to recent Centers for Medicare and Medicaid Services (CMS) rule changes and legislation affecting reimbursement and patient education. As government officials,...

2008-09-22 09:00:12

DEERFIELD, Ill., Sept. 22 /PRNewswire-FirstCall/ -- Baxter Healthcare Corporation today announced initiation of a Phase III clinical trial following U.S. Food and Drug Administration (FDA) review of its investigational new drug application to evaluate GAMMAGARD LIQUID [Immune Globulin Intravenous (IGIV)], marketed as KIOVIG in European Union, for the treatment of mild-to-moderate Alzheimer's disease. This trial is expected to be the first of two pivotal Phase III trials required to support...

2008-07-30 18:00:54

CHICAGO, July 30 /PRNewswire-USNewswire/ -- Results from clinical trials of three potential Alzheimer's therapies raise hope for new and better treatments of the disease, according to data reported today at the 2008 Alzheimer's Association International Conference on Alzheimer's Disease (ICAD 2008) in Chicago. A related study showed that taking antidementia drugs appears to have a positive impact on extending lifespan in those with Alzheimer's. These reports included: Eighteen-month...

2008-07-30 18:00:22

To: NATIONAL EDITORS Contact: Alzheimers Association media line: +1-312-335-4078, media@alz.org; ICAD 2008 press room, July 27-31: +1-312-949-3253 - Plus, Taking Antidementia Drugs Extends Lifespan Three Years in Alzheimers - CHICAGO, July 30 /PRNewswire-USNewswire/ -- Results from clinical trials of three potential Alzheimers therapies raise hope for new and better treatments of the disease, according to data reported today at the 2008 Alzheimers Association International Conference...

a9313bf0d82bc2559dcaabcd3673ec931
2008-07-30 12:15:00

U.S. health officials say they have been able to connect three deaths to a contaminated batch of the blood-thinning drug heparin. A spike in the number of allergic reactions by hospital patients injected with the drug prompted its manufacturer, Baxter International Inc., of suburban Chicago, to pull the heparin from distribution in February. Since then, the U.S. Food and Drug Administration has been examining reports of 93 deaths related to heparin. An FDA scientist told the Chicago Tribune...

ae57ded834184f1c673fa7c2a070c6b21
2008-05-15 12:58:17

Recalling how his newborn twins were nearly killed from an accidental drug overdose, actor Dennis Quaid testified before the U.S. Congress Wednesday, urging them to maintain the rights of patients to sue drugmakers for injuries. The Quaid twins were injured while in the hospital last year and mistakenly received an overdose of the blood-thinning drug Heparin, made by Baxter International Inc. Quaid and his wife have since sued the company, arguing that the drug is kept in bottles that are not...

8d5301d6b250593be084ac26f4d407431
2008-04-21 21:00:00

In a letter sent to Changzhou SPL Co., the Chinese manufacturer of an ingredient found in heparin, the Food and Drug Administration warned that the company did not have proper methods of ensuring that impurities are removed from the controversial blood-thinning drug. The letter was released just hours after Chinese officials announced that they doubted the contaminant, known as oversulfated chondroitin, was the root cause of several allergic reactions in U.S. patients. The FDA told Changzhou...


Word of the Day
monteith
  • A large punch-bowl of the eighteenth century, usually of silver and with a movable rim, and decorated with flutings and a scalloped edge. It was also used for cooling and carrying wine-glasses.
  • A kind of cotton handkerchief having white spots on a colored ground, the spots being produced by a chemical which discharges the color.
This word is possibly named after Monteith (Monteigh), 'an eccentric 17th-century Scotsman who wore a cloak scalloped at the hem.'
Related